develop a glutamate targeting peptide theranostics for neurodegenerative disorder

Created using ChatSlide

This presentation outlines a comprehensive approach to developing glutamate-targeted theranostics for neurodegenerative diseases. It emphasizes the need for innovative strategies to address unmet clinical needs, focusing on precision tools that enhance patient outcomes. Key topics include the strategic targeting of glutamate receptors, peptide design for effective delivery, and the integration of imaging with therapeutic payloads. The roadmap for clinical development highlights the importance...